Introduction
============

The cell wall is essential for viability conferring structural integrity on bacterial cells. Its main function is to enable a high osmotic pressure inside the cell to be maintained. Despite its rigidity, the cell wall has to be porous enough to permit passage of specific solutes and adaptable enough to allow cell expansion ([@b3]). The cell walls of eubacteria contain peptidoglycan (murein), a covalently linked macromolecular structure which is located immediately outside the cytoplasmic membrane and which is characteristic of these organisms ([@b30]).

The cell walls of Gram-positive bacteria, such as *Bacillus subtilis*, are composed of a thick peptidoglycan layer to which anionic polymers, including cell wall teichoic acids, and specific proteins are covalently bound. Peptidoglycan is made of glycan strands cross-linked by short peptides to form a three-dimensional meshwork ([@b3]). Although the initial steps of peptidoglycan and teichoic acid biosynthesis show some similarities, the sites of polymerization are distinct. Polymers of cell wall teichoic acids are formed intracellularly, whereas peptidoglycan polymerization occurs on the extracellular side of the membrane ([@b3]).

The biosynthesis of peptidoglycan is a highly complex process that proceeds in several stages. Initially, in six cytoplasmic reactions catalyzed by MurA to MurF, the UDP-MurNAc-pentapeptide precursor, UDP-*N* acetylmuramic acid, is synthesized. MraY then catalyzes the reaction of this precursor with the membrane acceptor, undecaprenyl phosphate, to yield lipid I. The addition of *N*-acetylglucosamine (GlcNAc) to lipid I by MurG leads to lipid II, which represents the complete disaccharide-pentapeptide unit ([@b37]). Lipid II is then transferred to the outside of the membrane by lipid II flippase ([@b16]). The next stage of peptidoglycan synthesis involves polymerization reactions on the outside surface of the cytoplasmic membrane catalyzed by penicillin-binding proteins (PBPs) and the incorporation of newly formed material into the existing peptidoglycan ([@b19]). Peptidoglycan synthesis in rod-shaped *B. subtilis* cells takes place along the cylindrical part of the cell and at the cell septum, but not at the cell poles.

A direct link between peptidoglycan synthesis and the cytoskeletal system is suggested by the interactions between the glycosyltransferase MurG and the cytoskeletal protein MreB ([@b8]; [@b24]) as well as the direct association of several PBPs with MreB and the membrane proteins MreC and MreD ([@b20]; [@b35]; [@b19]).

The bacterial cytoplasmic membrane is an inhomogeneous highly dynamic structure, which contains distinct domains differing in their phospholipid and protein composition, giving rise to defined membrane microenvironments ([@b10]). It has been suggested that lipid domains containing anionic phospholipids play an important role in compartmentalization of specific proteins in the membrane (Epand & [@b11]). Recently, lipid microdomains similar to the lipid rafts described in eukaryotic cells have been discovered in *B. subtilis*. These lipid rafts, likely enriched in polyisoprenoids, can be isolated together with specific proteins such as homologues of eukaryotic Flotillin1 and other proteins involved in transport and signaling ([@b22]).

Organization of phospholipid molecules within the *B. subtilis* cytoplasmic membrane into specific domains enriched in phosphatidylethanolamine ([@b38]; [@b26]), cardiolipin ([@b18]) and phosphatidylglycerol ([@b2]) has been observed. Phosphatidylethanolamine-rich domains are localized in the septal region of the membrane during vegetative growth and in the polar septum and forespore membrane during sporulation. Cardiolipin is preferentially localized at the cell poles and in the septal regions. Phosphatidylglycerol, the major negatively charged phospholipid in *B. subtilis*, was shown to be the principal component of lipid helix-like structures extending along the long axis of the cell. These lipid helices are recognized by the cell division protein MinD, indicating their possible involvement in cell division ([@b2]). These structures may also be employed in the localization of the secretory protein SecA, which exhibits a spiral pattern of localization dependent on the presence of anionic phospholipids ([@b4]). Moreover, it was shown recently that a cyclic lipopeptide antibiotic, daptomycin, preferentially interacts with lipid helices enriched in phosphatidylglycerol. Depletion of phosphatidylglycerol leads not only to decreased susceptibility to daptomycin but also to loss of the typical helical localization pattern observed in wild-type cells stained with a fluorescent derivate of daptomycin ([@b14]). Despite increasing recognition of their prevalence and importance in many cellular processes, it is still not understood how these domains of a unique phospholipid composition are formed.

Here, we present evidence that the presence of lipid domains in the cytoplasmic membrane is linked to the cell wall peptidoglycan. We analyzed lipid structures either in cells devoid of peptidoglycan through treatment with lysozyme or in cells depleted of MurG.

Materials and methods
=====================

Media and general methods
-------------------------

*Bacillus subtilis* cells were grown in LB media or DSM ([@b15]). Transformation of *B. subtilis* and other standard genetic techniques were carried out as described previously ([@b15]). When required, media were supplemented with erythromycin (1 μg mL^−1^) and lincomycin (25 μg mL^−1^). P~spac~-driven expression was induced using 1 mM isopropyl β-[d]{.smallcaps}-1-thiogalactopyranoside (IPTG).

Bacterial strains
-----------------

All *B. subtilis* strains used are derivatives of the wild-type PY79 strain ([@b39]). Strain IB1302 (PY79 *murG::pMutin4erm*), which harbors an IPTG-inducible copy of *murG*, was created by the insertion of the plasmid pMmurG1 (*bla erm PspacΔmurG*) into the *murG* locus and mutants were selected for erythromycin/lincomycin resistance.

Plasmids
--------

Plasmid pMmurG1 was constructed using standard procedures and amplified in *E. coli* MM294 (*endA1 hsdR17 supE44 thi-1 recA*^*+*^) ([@b1]). A 688-bp DNA fragment of the *murG* gene was amplified from PY79 chromosomal DNA using the primers murGBS (5′-GATGATGAT[GGATCC]{.ul}GACTGGGGGAAAAAAGAAATGCGA-3′) and murGBE (5′-GATGATGAT[GGATCC]{.ul}CGGTGATATACAGCACTTGA TAG-3′). The PCR fragment was digested with BamHI (sites are underlined in the primer sequence) and cloned into similarly cleaved pMutin4, an integration vector used for gene inactivation ([@b33]). Correct insertion in the vector was confirmed by restriction enzyme analysis and DNA sequencing.

Preparation of the cell spheroplasts
------------------------------------

*Bacillus subtilis* PY 79 strain was grown in liquid cultures in DSM. Each culture was inoculated from a fresh overnight plate to an OD~600\ nm~ of 0.1 and grown to mid-exponential phase (OD~600\ nm~ of 0.5). Samples of cell cultures were centrifuged (1 min at 2300 ***g***) and rapidly resuspended in 10 μL of 1× SMM (0.5 M sucrose, 20 mM maleic acid, and 20 mM MgCl~2~; pH 6.5) containing 1 mg mL^−1^ lysozyme ([@b12]; [@b27]). The mixture was mixed gently, and after approximately 10 min, a 0.5 μL sample was dropped directly onto 1% agarose pads prepared with LB medium. To check the viability of spheroplasts, staining with SYTO9 and propidium iodide from the Live/Dead BacLight Bacterial Viability and Counting Kit (Invitrogen) was performed.

Fluorescence microscopy and image acquisition
---------------------------------------------

*Bacillus subtilis* cultures were grown as liquid cultures in appropriate media as described above. To deplete MurG, the relevant culture was grown in DSM with 1 mM IPTG for 2 h and diluted into a medium lacking IPTG to an OD~600\ nm~ of 0.05 and incubated for an additional 2 h. For membrane visualization, the fluorescent dye FM 4-64 (Molecular Probes) at concentrations of 0.2--1 μg mL^−1^ and nonyl acridine orange (NAO; Molecular Probes) at concentrations of 0.05--0.1 μg mL^−1^ were used. Samples were also stained with DAPI (0.2 μg mL^−1^) to visualize DNA. For imaging peptidoglycan biosynthesis, fluorescent vancomycin was used as described previously ([@b6]; [@b32]). Briefly, fluorescent vancomycin was prepared by mixing BodipyFL vancomycin (Molecular Probes) and unlabeled vancomycin in a 1 : 1 ratio. The vancomycin/BodipyFL vancomycin mixture was added to growing cultures to a final concentration of 1 μg mL^−1^. The culture was then incubated for a further 20 min before examination by microscopy. Cells were examined under the microscope on 1% agarose-covered slides. When it was necessary to increase the cell density, cells were concentrated by centrifugation (3 min at 2300 ***g***) and resuspended in a small volume of supernatant prior to examination by microscopy. All images were obtained with an Olympus BX61 microscope, equipped with an Olympus DP30BW camera. Olympus [CellP]{.smallcaps} imaging software or Olympus [Image-Pro Plus]{.smallcaps} 6.0 software was used for image acquisition and analysis. For image deconvolution and figure rendering, the [Huygens Professional]{.smallcaps} (Scientific Volume Imaging) software package was used.

Results and discussion
======================

Helix-like lipid structures are not preserved in cells devoid of the peptidoglycan layer
----------------------------------------------------------------------------------------

In previous work using the fluorescent dyes FM 4-64, FM5-95, and FM1-43, we observed that the fluorescence signal in the membrane is distributed in a helical pattern. We also showed that phosphatidylglycerol is the main component of these helices ([@b2]). Analysis of strains in which DNA replication is inhibited revealed lipid domains identical to those observed in wild-type cells, indicating either that their formation is unaffected by inhibition of replication or that the structures already established are relatively stable ([@b25]).

Imaging of peptidoglycan biosynthesis with fluorescent derivatives of antibiotics demonstrated a helical distribution of the fluorescence signal along the cylindrical walls of *B. subtilis* cells ([Fig. 1a](#fig01){ref-type="fig"}) ([@b6]; [@b32]), a result suggesting that the peptidoglycan biosynthetic machinery is helically distributed. To examine whether the formation and persistence of helix-like lipid domains are dependent on cell wall peptidoglycan, we analyzed the membrane structure in cells in which the peptidoglycan layer has been disrupted by lysozyme treatment.

![Staining of *Bacillus subtilis* PY79 cells with fluorescent vancomycin. Fluorescent vancomycin was prepared by mixing BodipyFL vancomycin (Molecular Probes) and unlabeled vancomycin in a 1 : 1 ratio. The mixture was added to the growing cultures to give a final concentration of 1 μg mL^−1^, and the culture was incubated for a further 20 min. (a) Fluorescent vancomycin staining of vegetatively growing cells. A helical pattern of the fluorophore was observed indicating a helical distribution of the peptidoglycan biosynthetic machinery. Phase-contrast (A) and fluorescence images (B). (b) Fluorescent vancomycin staining of cells treated with lysozyme. Staining was performed as described above. Cells were collected by centrifugation, resuspended in 1× SMM containing 1 mg mL^−1^ lysozyme, and further incubated for 10 min. The vancomycin fluorescence signal is localized around the circumference of the spheroplasts indicating the presence of residual peptidoglycan. There is no helical pattern to the observed fluorescence in these cells. Phase-contrast (A) and fluorescence images (B). Scale bars represent 2 μm.](fml0325-0092-f1){#fig01}

To prepare spheroplasts, we treated wild-type *B. subtilis* cells, grown as described in Materials and methods, with lysozyme. Enzymatic removal of the cell wall led to the formation of spherical cells that were stably and viably (as established by the Live/Dead assay) maintained in buffers containing a high concentration of sucrose (0.5 M). Having stained these cells with fluorescent vancomycin, residual cell wall peptidoglycan was detected, indicating partial removal by lysozyme ([Fig. 1b](#fig01){ref-type="fig"}). However, no helical structures were observable in these rounded lysozyme-treated cells in contrast to the untreated cells ([Fig. 1a](#fig01){ref-type="fig"}). The spherical cells were treated with FM4-64, which preferentially stains negatively charged phospholipids ([Fig. 2aC](#fig02){ref-type="fig"}). In these spheroplasts, we did not observe same lipid domains as detected in untreated cells ([Fig. 2aA](#fig02){ref-type="fig"}). This indicates that these structures are not preserved in cells devoid/depleted of peptidoglycan and/or that lysozyme treatment removes a determinant that contributes to the organization of lipids into helical structures.

![Lipid domains in spheroplasts of the wild-type *Bacillus subtilis* strain PY79. (a) Visualization of FM4-64 signals in spheroplasts. Spheroplasts were prepared by enzymatic removal of peptidoglycan with lysozyme. FM4-64-stained anionic phospholipids in wild-type cells resuspended in SMM buffer that were not treated with lysozyme (A) and in cells treated with lysozyme (B and C). (B) Cells with partially removed peptidoglycan after 2 min of lysozyme treatment, and (C) spheroplasts after 10 min of lysozyme treatment. While in the cells untreated with lysozyme, helix-like lipid structures stained with FM4-64 are visible, in spheroplasts, the FM4-64 signals are on the opposite sides of the cells. The arrows show the accumulation of anionic lipids stained with FM4-64. (b) Staining of spheroplasts with NAO to visualize cardiolipin domains. NAO-stained cardiolipin domains in wild-type cells that were not treated with lysozyme (A) and in cells treated with lysozyme (B). NAO fluorescence signals in spheroplasts preponderate at the former cell poles (arrows), indicating enrichment in cardiolipin at these sites as observed in vegetative cells. In cells not treated with lysozyme, arrows show its accumulation at the cell poles and arrowheads show its accumulation at the division sites. Scale bars represent 2 μm.](fml0325-0092-f2){#fig02}

It is known that a second anionic phospholipid present in *B. subtilis* membranes, cardiolipin, is distributed heterogeneously and forms specific cardiolipin-rich domains in the septal and polar membranes ([Fig. 2bA](#fig02){ref-type="fig"}) ([@b18]). Treatment of spheroplasts with the cardiolipin-specific dye, NAO, revealed that the fluorescence signal is indeed focused at the former cell poles ([Fig. 2Bb](#fig02){ref-type="fig"}). The results show that while the spiral-like structures formed principally by phosphatidylglycerol and heralded by the FM4-64 dye are not preserved in protoplasted cells, the cardiolipin-rich domains are unchanged. Staining of spheroplasts with both fluorescence dyes revealed their co-localization in the most of protoplasted cells, indicating enrichment of these sites in the anionic phospholipids (not shown). It was reported recently that cardiolipin recognizes negative curvature of the lipid membrane in rod-shaped *E. coli* ([@b28]). This finding predicts a more even distribution of cardiolipin in spheroplasts. The localization of cardiolipin, and possibly phosphatidylglycerol too, to specific sites in protoplasted *B. subtilis* cells may be caused by the presence of residual peptidoglycan after the lysozyme treatment.

The lysozyme treatment of cells leads to the partial removal of the peptidoglycan layer and the formation of rounded spheroplasts. The formation of lipid helix-like structures may depend on the presence of intact peptidoglycan. Alternatively, it may be determined by other factors associated with the maintenance of cell shape. Actin homologues determine cell shape in *B. subtilis*. The discovery that the cytoskeletal proteins Mbl, MreB, and MreBH are organized into helical structures ([@b17]; [@b7]) proximal to the intracellular surface of the cytoplasmic membrane led to speculation on the relationship between these internal structures and the peptidoglycan synthetic machinery. Moreover, staining of cells with a fluorescent derivative of vancomycin revealed that new peptidoglycan is incorporated into the cell wall in a helical Mbl-dependent manner ([@b6]). Later, it was shown that the loss of the second major component of cell wall, wall teichoic acid polymers, has a dramatic effect on cellular morphology causing loss of rod shape ([@b5]).

However, other factors such as membrane curvature and/or preferential interactions between proteins and specific lipids may be determinants in the formation of lipid domains.

Lipid domains are not preserved in cells depleted of the transferase MurG
-------------------------------------------------------------------------

The biosynthesis of peptidoglycan is a complex multistep process that has been investigated in various bacteria ([@b37]). The initial cytoplasmic steps involve the formation of the intermediates, lipid I and lipid II. Lipid II, which is the substrate for subsequent polymerization reactions, is formed by the action of the transferase MurG ([@b36]), a key enzyme in peptidoglycan biosynthesis. To study the effect of peptidoglycan depletion on the formation lipid domains, we prepared a strain in which an IPTG-inducible *murG* is introduced at the *murG* locus. Depletion of MurG by cell culture in the absence of IPTG leads to arrest of cell growth, cell bulging, and ultimately cell lysis ([Fig. 3](#fig03){ref-type="fig"}). Similar effects were observed after the depletion of another key enzyme of peptidoglycan synthesis, MurE ([@b21]).

![Peptidoglycan staining and localization of lipid domains in IB1302 cells depleted of MurG. Cell cultures were initially grown in the presence of 1 mM IPTG for 2 h before dilution to an OD~600\ nm~ of 0.05 in media lacking IPTG and incubation for an additional 2 h. (a) Fluorescent vancomycin staining of peptidoglycan. In cells grown in the presence of IPTG, a helical pattern of fluorescence signal is observed, indicating a helical distribution of the peptidoglycan biosynthetic machinery similar to that in wild-type cells. However, in bulged cells that were grown without IPTG, no clear helical pattern of the fluorophore is observed. Instead, the fluorescence signal is accumulated at division sites where residual peptidoglycan synthesis occurred. Phase-contrast (A) and fluorescence images (B). (b) FM 4-64-stained anionic phospholipids. In the cells grown in the presence of IPTG, lipid domains similar to those observed in wild-type cells were detected. In cells, depleted of MurG, no such lipid structures are observable. Phase-contrast (A) and fluorescence images (B). (c) Cardiolipin domains stained with NAO. The arrow shows cardiolipin accumulation at the cell pole, and the arrowhead shows its accumulation at the division site in a way similar to that seen in wild-type cells. In bulged cells, the fluorescence signal is more evenly distributed in the membrane. Phase-contrast (A) and fluorescence images (B). Scale bars represent 2 μm.](fml0325-0092-f3){#fig03}

To determine whether, as expected, peptidoglycan biosynthesis is disturbed in cells depleted of MurG, we stained these cells with fluorescent vancomycin ([Fig. 3a](#fig03){ref-type="fig"}). In bulged cells, we observed a clear change in overall vancomycin staining and no helical distribution of the fluorescence signal. Instead, the signal is concentrated at division sites where a massive and rapid peptidoglycan synthesis occurs before the removal of inducer. Thus, the concentration of nascent peptidoglycan chains may remain high at these positions. It was shown previously that vancomycin binds to the terminal [d]{.smallcaps}-Ala-[d]{.smallcaps}-Ala of peptidoglycan precursors and to cell wall peptidoglycan that has yet to be cross-linked ([@b29]). As a result, labeled vancomycin can be used for staining sites of nascent peptidoglycan biosynthesis. A helical distribution of the vancomycin signal in wild-type *B. subtilis* cells implies a helical distribution of the sites of insertion of the nascent peptidoglycan into the cell wall ([@b6]; [@b32]). Accumulation of the fluorescence signal at division sites in cells depleted of either MurG or MurE ([@b6]) shows that residual peptidoglycan synthesis occurs only at sites of septation.

To examine whether helix-like lipid structures are preserved under conditions of MurG depletion, we stained the *murG* mutant strain with FM4-64 ([Fig. 3b](#fig03){ref-type="fig"}). We observed that in the most of these cells, in bulged and also in rod-shaped cells, the FM dye does not exhibit a clear spiral pattern of localization, indicating that helix-like lipid domains are not preserved in cells with defects in peptidoglycan biosynthesis. To determine whether the distribution of cardiolipin-rich domains is also altered in these cells, we stained this mutant strain with NAO ([Fig. 3c](#fig03){ref-type="fig"}). Under conditions of MurG depletion, while in some more elongated cells, the fluorescence signal remains concentrated at the cell poles and division sites, in bulged cells, the signal is more evenly distributed in the membrane. These results suggest that disruption of peptidoglycan synthesis either prevents the formation and establishment of specific lipid domains such as those found in wild-type cells or causes disassembly of existing domains. It was shown previously that *E. coli* MurG binds to the membrane by direct interaction with phospholipids and preferential interaction with cardiolipin ([@b34]). Our results confirm this link between peptidoglycan synthesis and membrane lipid domains. A direct association of MurG and the cytoskeletal protein MreB in *E. coli* ([@b24]) and the dependence of MurG localization on helical cables of MreB in *Caulobacter crescentus* ([@b8]) also imply a close relationship between peptidoglycan synthesis and the preservation of cell shape.

The maintenance of cell shape and its connection with the peptidoglycan synthetic machinery has already been demonstrated ([@b20]; [@b31]; [@b23]). Recently, coupled motion of MreB and the peptidoglycan elongation machinery around the cell has been observed ([@b9]; [@b13]). It was shown that cell wall synthesis itself provides the driving force for MreB movement. Here, we present evidence that the formation and/or preservation of lipid domains within the cytoplasmic membrane may be linked to the integrity of cell wall peptidoglycan. We hypothesize that the association of the cytoskeletal system inside the cell with peptidoglycan synthesis outside the cell may place constraints on the distribution of phospholipids in the intervening membrane leading to the creation and stabilization of helix-like lipid domains. Further experiments are required to test this prediction, to fully understand how these domains are formed, and to determine what factors preserve these structures in the *B. subtilis* cell membrane.
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